162 related articles for article (PubMed ID: 35135471)
1. Gut bacterial metabolite Urolithin A inhibits myocardial fibrosis through activation of Nrf2 pathway in vitro and in vivo.
Chen P; Pei J; Wang X; Tai S; Tang L; Hu X
Mol Med; 2022 Feb; 28(1):19. PubMed ID: 35135471
[TBL] [Abstract][Full Text] [Related]
2. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
3. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice.
Li X; Han D; Tian Z; Gao B; Fan M; Li C; Li X; Wang Y; Ma S; Cao F
Cell Physiol Biochem; 2016; 39(4):1521-36. PubMed ID: 27614871
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
Liu X; Xu Y; Deng Y; Li H
Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin ameliorates cardiac fibrosis after myocardial infarction by regulating the Nrf2/NADPH/ROS pathway.
Wang Q; Liu AD; Li TS; Tang Q; Wang XC; Chen XB
Peptides; 2021 Oct; 144():170613. PubMed ID: 34314760
[TBL] [Abstract][Full Text] [Related]
6. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis.
Yang W; Zhang S; Zhu J; Jiang H; Jia D; Ou T; Qi Z; Zou Y; Qian J; Sun A; Ge J
J Mol Cell Cardiol; 2019 Sep; 134():119-130. PubMed ID: 31299216
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory Effects of Oxymatrine on Transdifferentiation of Neonatal Rat Cardiac Fibroblasts to Myofibroblasts Induced by Aldosterone via Keap1/Nrf2 Signaling Pathways In Vitro.
Yang Y; Chen S; Tao L; Gan S; Luo H; Xu Y; Shen X
Med Sci Monit; 2019 Jul; 25():5375-5388. PubMed ID: 31325292
[TBL] [Abstract][Full Text] [Related]
8. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
9. Mangiferin activates Nrf2 to attenuate cardiac fibrosis via redistributing glutaminolysis-derived glutamate.
Song J; Meng Y; Wang M; Li L; Liu Z; Zheng K; Wu L; Liu B; Hou F; Li A
Pharmacol Res; 2020 Jul; 157():104845. PubMed ID: 32353588
[TBL] [Abstract][Full Text] [Related]
10. Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7.
Yuan J; Chen H; Ge D; Xu Y; Xu H; Yang Y; Gu M; Zhou Y; Zhu J; Ge T; Chen Q; Gao Y; Wang Y; Li X; Zhao Y
Cell Physiol Biochem; 2017; 42(6):2207-2219. PubMed ID: 28817807
[TBL] [Abstract][Full Text] [Related]
11. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation.
Lei H; Wu D; Wang JY; Li L; Zhang CL; Feng H; Fu FY; Wu LL
Basic Res Cardiol; 2015; 110(4):35. PubMed ID: 25962701
[TBL] [Abstract][Full Text] [Related]
12. Dengzhan Shengmai capsule attenuates cardiac fibrosis in post-myocardial infarction rats by regulating LTBP2 and TGF-β1/Smad3 pathway.
Wang M; Wang M; Zhao J; Xu H; Xi Y; Yang H
Phytomedicine; 2023 Jul; 116():154849. PubMed ID: 37163903
[TBL] [Abstract][Full Text] [Related]
13. Notch signaling inhibits cardiac fibroblast to myofibroblast transformation by antagonizing TGF-β1/Smad3 signaling.
Zhou XL; Fang YH; Wan L; Xu QR; Huang H; Zhu RR; Wu QC; Liu JC
J Cell Physiol; 2019 Jun; 234(6):8834-8845. PubMed ID: 30317638
[TBL] [Abstract][Full Text] [Related]
14. Urolithin B, a gut microbiota metabolite, protects against myocardial ischemia/reperfusion injury via p62/Keap1/Nrf2 signaling pathway.
Zheng D; Liu Z; Zhou Y; Hou N; Yan W; Qin Y; Ye Q; Cheng X; Xiao Q; Bao Y; Luo J; Wu X
Pharmacol Res; 2020 Mar; 153():104655. PubMed ID: 31996327
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model.
Yang R; Song Z; Wu S; Wei Z; Xu Y; Shen X
Atherosclerosis; 2018 Dec; 279():23-31. PubMed ID: 30399463
[TBL] [Abstract][Full Text] [Related]
16. miR-21 promotes cardiac fibroblast-to-myofibroblast transformation and myocardial fibrosis by targeting Jagged1.
Zhou XL; Xu H; Liu ZB; Wu QC; Zhu RR; Liu JC
J Cell Mol Med; 2018 Aug; 22(8):3816-3824. PubMed ID: 29808534
[TBL] [Abstract][Full Text] [Related]
17. Intermedin 1-53 Inhibits Myocardial Fibrosis in Rats by Down-Regulating Transforming Growth Factor-β.
Fang J; Luan J; Zhu G; Qi C; Yang Z; Zhao S; Li B; Zhang X; Guo N; Li X; Wang D
Med Sci Monit; 2017 Jan; 23():121-128. PubMed ID: 28065931
[TBL] [Abstract][Full Text] [Related]
18. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
19. Limb-bud and Heart (LBH) mediates proliferation, fibroblast-to-myofibroblast transition and EMT-like processes in cardiac fibroblasts.
Wu A; Zhang L; Chen J; Li H; Yang P; Chen M; Liu Q
Mol Cell Biochem; 2021 Jul; 476(7):2685-2701. PubMed ID: 33666830
[TBL] [Abstract][Full Text] [Related]
20. Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts.
Li T; Zhuang Y; Yang W; Xie Y; Shang W; Su S; Dong X; Wu J; Jiang W; Zhou Y; Li Y; Zhou X; Zhang M; Lu Y; Pan Z
FASEB J; 2021 Feb; 35(2):e21162. PubMed ID: 33150686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
